Filing Details

Accession Number:
0001562180-22-001077
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-02-03 17:31:18
Reporting Period:
2022-02-01
Accepted Time:
2022-02-03 17:31:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1395937 Syndax Pharmaceuticals Inc SNDX Pharmaceutical Preparations (2834) 320162505
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1891979 Alexander Nolte C/O Syndax Pharmaceuticals, Inc.
35 Gatehouse Drive, Building D, Floor 3
Waltham MA 02451
Chief Accounting Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-01-31 968 $12.39 968 No 4 J Direct
Common Stock Disposition 2022-02-01 968 $16.65 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 J Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to buy) Acquisiton 2022-02-02 30,000 $15.79 30,000 $15.79
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
30,000 2032-02-02 No 4 A Direct
Footnotes
  1. The Reporting Person is voluntarily filing this Form 4 to report the acquisition of 968 shares by the Reporting Person on 01/31/2022 pursuant to the Issuer's Employee Stock Purchase Plan.
  2. 1/48th of the shares subject to the option shall vest monthly over a four-year period.